Literature DB >> 10537019

Senescence-accelerated mouse (SAM): a biogerontological resource in aging research.

T Takeda1.   

Abstract

The senescence-accelerated mouse (SAM), consisting of 14 senescence-prone inbred strains (SAMP) and 4 senescence-resistant inbred strains (SAMR) has been under development since 1970 through the selective inbreeding of AKR/J strain mice donated by the Jackson laboratory in 1968, based on the data of the grading score of senescence, life span, and pathologic phenotypes. The characteristic feature of aging common to all SAMP and SAMR mice is accelerated senescence and normal aging, respectively. Furthermore, SAMP and SAMR strains manifest various pathobiological phenotypes which include such neurobiological phenotypes as deficits in learning and memory, emotional disorders, abnormal circadian rhythms, brain atrophy, hearing impairment, etc., and are often characteristic enough to differentiate the strains. Various efforts are currently being made using the SAM model to clarify the underlying mechanisms in accelerated senescence as well as the etiopathogenic mechanisms in age-associated pathobiologies. Genetic background and significance of SAM development are discussed.

Entities:  

Mesh:

Year:  1999        PMID: 10537019     DOI: 10.1016/s0197-4580(99)00008-1

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  56 in total

1.  Mitochondria and aging: innocent bystanders or guilty parties?

Authors:  K Tońska; A Sołyga; E Bartnik
Journal:  J Appl Genet       Date:  2009       Impact factor: 3.240

Review 2.  Animal models in the drug discovery pipeline for Alzheimer's disease.

Authors:  Debby Van Dam; Peter Paul De Deyn
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

3.  Diastolic dysfunction is associated with cardiac fibrosis in the senescence-accelerated mouse.

Authors:  Alana L Reed; Atsuko Tanaka; Dan Sorescu; Hong Liu; Euy-Myoung Jeong; Megan Sturdy; Erik R Walp; Samuel C Dudley; Roy L Sutliff
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-07-01       Impact factor: 4.733

4.  Melatonin protects lung mitochondria from aging.

Authors:  Darío Acuña-Castroviejo; Miguel Carretero; Carolina Doerrier; Luis C López; Laura García-Corzo; Jesús A Tresguerres; Germaine Escames
Journal:  Age (Dordr)       Date:  2011-05-26

5.  Effect of long-term treatment with melatonin on vascular markers of oxidative stress/inflammation and on the anticontractile activity of perivascular fat in aging mice.

Authors:  Claudia Agabiti-Rosei; Gaia Favero; Carolina De Ciuceis; Claudia Rossini; Enzo Porteri; Luigi Fabrizio Rodella; Lorenzo Franceschetti; Anna Maria Sarkar; Enrico Agabiti-Rosei; Damiano Rizzoni; Rita Rezzani
Journal:  Hypertens Res       Date:  2016-08-18       Impact factor: 3.872

Review 6.  Modulation of Vascular Reactivity by Perivascular Adipose Tissue (PVAT).

Authors:  Claudia Agabiti-Rosei; Anna Paini; Carolina De Ciuceis; Sarah Withers; Adam Greenstein; Anthony M Heagerty; Damiano Rizzoni
Journal:  Curr Hypertens Rep       Date:  2018-05-07       Impact factor: 5.369

Review 7.  Viral infection and aging as cofactors for the development of pulmonary fibrosis.

Authors:  Payal K Naik; Bethany B Moore
Journal:  Expert Rev Respir Med       Date:  2010-12       Impact factor: 3.772

Review 8.  Animal models for fracture treatment in osteoporosis.

Authors:  Marcus Egermann; J Goldhahn; E Schneider
Journal:  Osteoporos Int       Date:  2005-03-05       Impact factor: 4.507

9.  Rhein lysinate increases the median survival time of SAMP10 mice: protective role in the kidney.

Authors:  Gang Hu; Jiang Liu; Yong-zhan Zhen; Rong Xu; Yu Qiao; Jie Wei; Ping Tu; Ya-jun Lin
Journal:  Acta Pharmacol Sin       Date:  2013-03-11       Impact factor: 6.150

10.  A novel mouse model of the aged brain: Over-expression of the L-type voltage-gated calcium channel CaV1.3.

Authors:  Jamie N Krueger; Shannon J Moore; Rachel Parent; Brandon C McKinney; Amy Lee; Geoffrey G Murphy
Journal:  Behav Brain Res       Date:  2016-06-28       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.